Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
WidePoint Corporation, provider of Trusted Mobility Management solutions, reports 4th Quarter and Full Year 2025 financial results.
-
Austin, March 19, 2026 (GLOBE NEWSWIRE) -- The Premium Messaging Market size was valued at USD 80.20 billion in 2025 and is expected to reach USD 146.08 billion by 2035, expanding at a CAGR of 6.18%...
-
WidePoint Corporation (NYSE American: WYY) will hold a conference call on March 25, 2026, at 4:30pmET to discuss its Q4 2025 and FY 2025 financial results.
-
PR N° : P4760S STMicroelectronics ouvre une nouvelle ère dans la technologie ultra-large bande pour les applications automobiles et les appareils intelligents Présentation de la famille ST64UWB : la...
-
STMicroelectronics propels new era of ultra-wideband technology for automotive and smart device applications Introducing the ST64UWB family: the first fully integrated ultra-wideband (UWB) solution...
-
WidePoint announces a phase one $1.3 million contract award to its Managed Services division with one of the leading bottlers in the beverage industry.
-
In the RELIEVE UCCD LTE phase 2b study, duvakitug showed robust, durable efficacy for an additional 44 weeks in UC and CD patients who had responded after 14 weeks of inductionDuvakitug was well...
-
Les données de phase IIb de l’étude d’entretien sur le duvakitug de Sanofi et Teva ont démontré une efficacité durable cliniquement significative dans la colite ulcéreuse et la maladie de Crohn Dans...
-
Sanofi and Teva’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy in ulcerative colitis and Crohn’s disease In the RELIEVE UCCD LTE phase 2b study, duvakitug...
-
MJH Life Sciences launches Dermatology Times NP/PA Connect and CME meetings to advance dermatology NP/PA education.